ArticlebioRxiv : the preprint server for biology2026

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Brett A Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.